Leprechaunism.
Nagarathinam S, Baalann KP.
Pan Afr Med J. 2021 Dec 16;40:232. doi: 10.11604/pamj.2021.40.232.31738. eCollection 2021.
Leprechaunism (Donohue syndrome).
Ghosh U, Mathai S.
Indian Pediatr. 2015 Aug;52(8):724.
Leprechaunism.
EVANS PR.
Arch Dis Child. 1955 Dec;30(154):479-83. doi: 10.1136/adc.30.154.479.
[Leprechaunism].
Tohma T.
Ryoikibetsu Shokogun Shirizu. 2001;(34 Pt 2):81-2.
Leprechaunism/Donohue syndrome/insulin receptor gene mutations: a syndrome delineation story from clinicopathological description to molecular understanding.
Kosztolányi G.
Eur J Pediatr. 1997 Apr;156(4):253-5. doi: 10.1007/s004310050594.
New classification and diagnostic criteria for insulin resistance syndrome.
Ogawa W, Araki E, Ishigaki Y, Hirota Y, Maegawa H, Yamauchi T, Yorifuji T, Katagiri H.
Endocr J. 2022 Feb 28;69(2):107-113. doi: 10.1507/endocrj.EJ21-0725. Epub 2022 Feb 1.
Atypical Forms of Diabetes.
Feingold KR.
2025 Mar 10. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Leprechaunism and related syndromes with primary insulin resistance: heterogeneity of molecular defects.
Rechler MM.
Prog Clin Biol Res. 1982;97:245-81.
[Leprechaunism(Donohue syndrome)].
Morooka K.
Ryoikibetsu Shokogun Shirizu. 2000;(30 Pt 5):207-8.
LEPRECHAUNISM (DONOHUE'S SYNDROME).
KALLO A, LAKATOS I, SZIJARTO L.
J Pediatr. 1965 Feb;66:372-9. doi: 10.1016/s0022-3476(65)80195-0.
